H2020Докторантска мрежа2021–2025

MINDSHIFT · Mechanistic Integration of vascular aND endocrine pathways for Subtyping Hypertension: an Innovative network approach for Future generation research Training

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2021-01-01 → 2025-03-31
Финансиране от ЕС
4 124 385 €
Участници
6
Схема
MSCA-ITN

Линиите свързват координатора с партньорите.

Накратко на български

Взаимодействията между съдовите и ендокринните пътища при хипертонията, като например влиянието на хормоните върху кръвоносните съдове, се анализират чрез мрежов подход. Това помага за определяне на видове хипертония, което може да подобри превенцията и лечението на заболяването.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Mechanistic Integration of vascular aND endocrine pathways for Subtyping Hypertension: an Innovative network approach for Future generation research Training

Hypertension is the key determinant of cardiovascular disease and the No.1 ‘silent killer’ worldwide. Despite progress in understanding the causes of hypertension and improvements in clinical management, >85 million people in Europe suffer from cardiovascular disease, costing the EU €210 billion/year. Currently, there is a crucial gap in understanding the dynamic interactions between vascular and endocrine pathways in hypertension. Such knowledge would facilitate redefinition of hypertension subtypes to improve current prevention and treatment. The overall aim of MINDSHIFT is to improve vascular health management by redefining hypertension subtypes, based on the network dynamics between vascular and endocrine systems. The commensurate specific research objectives were as follows: • To elucidate inflammatory, metabolic, and fibrotic pathways in vascular pathophysiology of hypertension; • To characterise (the dynamics of) vascular influences on endocrine derangements; • To elucidate the mechanistic role of key regulatory endocrine pathways in hypertension; • To characterise (the dynamics of) endocrine influences on micro- and macrovascular dysfunction; • To establish a multi-scale and integrative framework to capture, evaluate, and exploit the new understandings. MINDSHIFT-ITN has fully embraced its network approach, as planned and whilst developing, through the following coherent elements and actions: • Vascular and Endocrine research had a 50-50% balanced contribution. • Periodic online and in-person MINDSHIFT meetings, as well as dedicated sessions at conferences in the cardiovascular/hypertension field, facilitated creative interactions between project teams. • Joint/Double doctorates and related secondments were set up to facilitate new collaboration across the vascular and endocrine research fields. • MINDSHIFT created a framework for the mechanistic integration of knowledge by promoting the collaborative and collective creative capacity of its community of researchers. • The professional training track of the ESRs ran in parallel with a supervisors’ track, with events and training, to develop the ITN as a sustainable organization. • A first-ever formal accreditation by The Recess College for “Partnership Working in Science Networks”, developed through MINDSHIFT but applicable to doctoral training networks. • At present, a new core group is forming and planning next initiatives to further support the MINDSHIFT ‘Hypertension School’ in the wider science network.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Hypertension is the key determinant of cardiovascular disease and the No.1 ‘silent killer’ of humans worldwide. Despite progress in understanding the causes of hypertension and improvements in clinical management, >85 million people in Europe suffer from cardiovascular disease, costing the EU €210 billion/year. Currently, there is a crucial gap in understanding the dynamic interactions between vascular and endocrine pathways in hypertension. Such knowledge would facilitate redefinition of hypertension subtypes to improve current prevention and treatment. MINDSHIFT will offer a top-level interdisciplinary research programme to bridge this gap, using an integrative framework approach fed by new data and insights from cutting-edge experimental and clinical studies. To enable this advance, MINDSHIFT will implement and run an innovative EJD-programme, combining first-class scientific research with in-depth professional and transferable competence-skills trainings. ESRs will develop the integrative and entrepreneurial capacities that hypertension research demands by nature. Above and beyond, the programme will challenge the ESRs to build their capacity for self-directed learning, career development and personal-professional leadership. The highly capable academic and non-academic partners in MINDSHIFT have co-designed an extraordinary high-quality programme of research projects and network-wide training elements, to achieve the required and sustainable impacts on the ESR careers, scientific results and ITN-wide learning and innovation. Based on the excellent synergies and shared commitments, the MINDSHIFT consortium seeks to establish a European School for Hypertension Research, to propel future health science and industry towards more effective prevention of and cure for this silent killer.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз